Posted from: Monday, October 28, 2013 - 04:09 PM - Present

DRUG RECALL - Metoclopramide Injection USP used for Treatment of Gastric Esophageal Reflux Disease

October 1, 2013, Hospira, Inc. has issued a voluntary recall of Metoclopramide Injection, USP.  The recall was due to a vial defect where particles were found inside of the vials. The affected lot is 28-104-DK (the lot may be followed by a 1) with an expiration date of October 1, 2014.

The particles found in the containers which prompted the recall were identified as glass strands.  If the particles go unnoticed, there is potential for severe injury.

Metoclopramide is used to treat gastric esophageal reflux disease.  Metoclopramide also treats symptoms of gastroparesis in patients with diabetes.

Although, no adverse health reactions have been associated with this recall, patients in possession of this product are asked to return it to the pharmacy or doctor’s office at which it was obtained.  If you have any questions about this recall please contact your local retail pharmacist or speak to your doctor.

Adverse events that may be related to the use of this product may also be reported to the United States Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting Program either online, by regular mail or by fax:

Online - www.fda.gov/medwatch/report.htm

Regular Mail - use postage-paid FDA form 3500 available at: www.fda.gov/MedWatch/getforms.htm. Mail the form to: MedWatch, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787

Fax - 1-800-FDA-0178

Last Updated Monday, April 24, 2017 - 02:38 PM.